A new blog from the Center for Global Development lists complete childhood immunization as one of the 10 most cost-effective nutrition interventions. Read the piece here: ow.ly/Vyuv50T4e6O

Call for abstracts for a session on equitable access to COVID-19 vaccines in Africa to be held at the 4th International Conference on Public Health in Africa from Nov. 25-29, 2024, in Rabat, Morocco. Submit your abstract by Sept. 6, 2024: ow.ly/PnJg50T5mNk African Health Economics and Policy Association

You can now submit your abstract for #IHEA 2025! Submissions are open for individual abstracts or organized session proposals for the 2025 IHEA Congress, which will be held in Bali, Indonesia July 19-23, 2025. The deadline is Nov. 19, 2024 International Health Economics Association (IHEA) ow.ly/CLIo50T6Rrq

The Danish Society for Tropical Medicine and International Health and School of Global Health - University of Copenhagen are holding a symposium on financing primary health care in low- and middle-income countries on September 10, 2024. Find out more and register for free: ow.ly/fQT150T6S3Y

In an article for GHJournal, authors from Africa CDC, Pandemic Action Network, @InstitutPasteur de Bangui, Afrexim Bank, and UCT analyze the African and global pandemic financing initiatives and ways forward for policymakers and the global health community: ow.ly/QO7k50T6Slh?

.Results for Development have developed a new tool to support the costing of national and sub-national multiple micronutrient supplements introduction and scale-up roadmaps. Find out more here: immunizationeconomics.org/recent-activit…

A new study led by PATH sought to identify the programmatic and operational factors associated with variations in economic costs for #HPV #vaccine delivery within and across six low- and middle-income countries. Read the publication here: ow.ly/Yzuz50TcyhY

We are pleased to announce the publication of research principles for studies that aim to estimate the cost of reaching zero-dose children. This document was developed following a meeting key immunization costing stakeholders in April 2024. #ZeroDose ow.ly/2eFP50TejER

Apply for a health economics consultancy with World Health Organization (WHO) in Egypt to provide technical support on issues relating to vaccine, immunization policy, and strategic planning financing. The closing date for applications is September 16, 2024: ow.ly/5F1C50TfqKe

A new modeling study of RSV prevention strategies in Argentina found that either a long-acting monoclonal antibody (mAb) or maternal RSV vaccine are worth considering when priced at <US$50 per dose. Read the publication in Vaccine: ow.ly/Usrq50TfKzv

As part of their Zero-Dose Learning Week 2024, @Gavi is hosting a learning event Sept. 11 for broad dissemination of the emerging zero-dose evidence, including on the cost of reaching zero-dose children. Find out more and register to attend virtually: ow.ly/HzGn50TgJgU

The Center for Effective Global Action (CEGA) has developed a tool for planning cost-effectiveness research to foster collaboration between cost and impact evaluation research. Browse the Costing Pre-analysis Planning template from CEGA Program Scientist, Liz Brown: ow.ly/gL5p50TfLft

Don't forget to register for tomorrow's webinar as part of Zero-Dose Learning Week from Gavi, the Vaccine Alliance, and hear presentations from some of our immunization economics community members on estimating the cost of reaching zero-dose children.

.UNICEF has released an update to the standard costs of vaccinating a child. First developed in 2020, this updated version was produced using 2024 vaccine prices and schedule assumptions: ow.ly/S63P50TmkHE

A new publication in Vaccine: X discusses the barriers to HPV vaccination in sub-Saharan Africa, lessons learned from sub-Saharan African countries that have implemented national HPV vaccination programs, and the future of HPV vaccination: immunizationeconomics.org/recent-activit…

A new study published in Nature Medicine estimates the the health-economic burden of #Lassa fever throughout West Africa and projects impacts of a series of vaccination campaigns: ow.ly/V6jQ50Tp5tG

A new study in the Lancet Global Health has found that delays in pneumococcal conjugate vaccine (PCV) roll-out globally and low PCV coverage have cost many lives. Read the modelling study from NUS and London School of Hygiene & Tropical Medicine: ow.ly/oNt650Tp61B

We have signed an agreement with Bavarian Nordic to rapidly secure 500,000 doses of #mpox vaccines for Africa for delivery in 2024. UNICEF